Roth Capital reiterated coverage on AzurRx BioPharma with a new price target
$AZRX
Major Pharmaceuticals
Health Care
Roth Capital reiterated coverage of AzurRx BioPharma with a rating of Buy and set a new price target of $5.00 from $7.00 previously
Save time and jump to the most important pieces.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 8/2/2021 | $2.50 → $2.00 | Buy | HC Wainwright & Co. |
8-K - First Wave BioPharma, Inc. (0001604191) (Filer)
8-K - First Wave BioPharma, Inc. (0001604191) (Filer)
8-K - AzurRx BioPharma, Inc. (0001604191) (Filer)